STOCKHOLDERS' DEFICIT (Tables)
|
3 Months Ended |
Mar. 31, 2024 |
|---|
| Stockholders Equity Note [Abstract] |
|
| Summary of assumptions used to value the warrants |
The following table presents the assumptions used to value the warrants:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2024 |
|
|
December 31, 2023 |
|
|
March 31, 2023 |
|
|
January 2023 |
Stock price |
|
$ |
0.11 |
|
|
$ |
0.10 |
|
|
$ |
0.30 |
|
|
$0.31 - $0.49 |
Exercise price |
|
$0.47 - $0.50 |
|
|
$0.47 - $0.50 |
|
|
$0.47 - $4.50 |
|
|
$0.47 - $4.50 |
Expected term |
|
3.78-3.82 years |
|
|
4.03-4.24 years |
|
|
4.78-4.83 years |
|
|
5 years |
Risk-free rate |
|
4.32%-4.33% |
|
|
3.90%-3.92% |
|
|
|
3.62 |
% |
|
3.53%-3.66% |
Dividend yield |
|
— |
|
|
— |
|
|
— |
|
|
— |
Volatility |
|
142.88% - 143.59% |
|
|
129.40%-130.23% |
|
|
122.09% - 122.53% |
|
|
116.40% - 119.14% |
|
| Summary of outstanding warrants |
A summary of outstanding warrants as of March 31, 2024 and December 31, 2023 is presented below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2024 |
|
|
December 31, 2023 |
|
|
|
Number of
Warrants |
|
|
Weighted‑
Average
Exercise
Price |
|
|
Number of
Warrants |
|
|
Weighted‑
Average
Exercise
Price |
|
Warrants outstanding, beginning of period |
|
|
4,732,391 |
|
|
$ |
0.95 |
|
|
|
6,610,520 |
|
|
$ |
2.22 |
|
Granted |
|
|
— |
|
|
|
— |
|
|
|
8,500,000 |
|
|
|
4.03 |
|
Exercised |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Cancelled, forfeited or expired |
|
|
— |
|
|
|
— |
|
|
|
(10,378,129 |
) |
|
|
4.23 |
|
Warrants outstanding, end of period |
|
|
4,732,391 |
|
|
$ |
0.95 |
|
|
|
4,732,391 |
|
|
$ |
0.95 |
|
Warrants exercisable end of period |
|
|
4,732,391 |
|
|
$ |
0.95 |
|
|
|
4,732,391 |
|
|
$ |
0.95 |
|
|
| Schedule of fair value of conversion feature liabilities |
The following table presents the assumptions used on the recent dates on which options were granted by the Company. The risk‑free interest rate is based on the implied yield available on U.S. Treasury issues with a term approximating the expected life of the options depending on the date of the grant and expected life of the respective options.
|
|
|
|
|
|
|
|
|
|
|
January 2024 |
|
|
January 2023 |
|
Stock Price |
|
$ |
0.11 |
|
|
$ |
0.31 |
|
Exercise Price |
|
$ |
0.15 |
|
|
$ |
4.50 |
|
Expected term |
|
5-5.75 years |
|
|
5-6 years |
|
Risk-Free Rate |
|
3.80-3.81% |
|
|
3.51-3.53% |
|
Dividend Yield |
|
— |
|
|
— |
|
Volatility |
|
127.39-136.00% |
|
|
108.16-116.40% |
|
|
| Summary of stock option activity |
A summary of outstanding stock options as of March 31, 2024 and December 31, 2023 is presented below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2024 |
|
|
December 31, 2023 |
|
|
|
Number of
Options |
|
|
Weighted‑
Average
Exercise
Price |
|
|
Number of
Options |
|
|
Weighted‑
Average
Exercise
Price |
|
Options outstanding, beginning of period |
|
|
3,223,881 |
|
|
$ |
5.97 |
|
|
|
4,660,787 |
|
|
$ |
5.08 |
|
Granted or deemed granted |
|
|
2,360,000 |
|
|
$ |
0.15 |
|
|
|
1,250,000 |
|
|
$ |
4.50 |
|
Exercised |
|
|
— |
|
|
$ |
— |
|
|
|
— |
|
|
$ |
— |
|
Cancelled, forfeited and expired |
|
|
(252,330 |
) |
|
$ |
3.20 |
|
|
|
(2,686,906 |
) |
|
$ |
3.74 |
|
Options outstanding, end of period |
|
|
5,331,551 |
|
|
$ |
3.52 |
|
|
|
3,223,881 |
|
|
$ |
5.97 |
|
Options exercisable, end of period |
|
|
4,350,051 |
|
|
$ |
3.73 |
|
|
|
2,373,881 |
|
|
$ |
6.50 |
|
Options available for future grant |
|
|
360,000 |
|
|
|
|
|
|
2,750,000 |
|
|
|
|
|